Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Alpha Tau Medical Ltd. Ordinary Shares (DRTS)

https://www.alphatau.com

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/08/2022

Market Cap

153,552,960

Shares Outstanding

69,470,000

Weighted SO

69,473,825

Total Employees

N/A

Upcoming Earnings

08/26/2024

Similar Tickers

EYEN --.--%

OCUL --.--%

TNYA --.--%

INZY --.--%

MNOV --.--%

ELYM --.--%

MOLN --.--%

CSBR --.--%

Beta

0.7580

Last Div

0.0000

Range

1.75-4.25

Chg

-0.0400

Avg Vol

36814

Mkt Cap

153552960

Exch

NASDAQ

Country

IL

Phone

972 3 577 4115

DCF Diff

2.1553

DCF

0.0365

Div Yield

0.0000

P/S

0.0000

EV Multiple

-4.5428

P/FV

2.0768

Div Yield %

0.0000

P/E

-5.5640

PEG

-0.2681

Payout

0.0000

Current Ratio

11.6555

Quick Ratio

11.6555

Cash Ratio

0.9105

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

682.4209

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0010

ROA

-0.2876

ROE

-0.3375

ROCE

-0.4057

NI/EBT

0.9990

EBT/EBIT

0.7609

EBIT/Rev

0.0000

Debt Ratio

0.0671

D/E

0.0871

LT Debt/Cap

0.0681

Total Debt/Cap

0.0801

Int Coverage

0.0000

CF/Debt

0.0000

Equity Multi

1.2976

Rec Turnover

0.0000

Pay Turnover

0.5349

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

0.0000

FCF/Share

0.0000

Cash/Share

1.0612

OCF/Sales

0.0000

FCF/OCF

0.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

2.0768

P/B

2.0768

P/S

0.0000

P/E

-5.5640

P/FCF

0.0000

P/OCF

0.0000

P/CF

0.0000

PEG

-0.2681

P/S

0.0000

EV Multiple

-4.5428

P/FV

2.0768

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 20, 09:15 Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. Nov 29, 08:30 Alpha Tau to Participate in Sidoti Small-Cap Conference GlobeNewswire Inc. Nov 28, 08:30 Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer GlobeNewswire Inc. Nov 20, 08:30 Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer Benzinga Nov 17, 13:00 Analyst Ratings for Alpha Tau Medical GlobeNewswire Inc. Nov 16, 16:30 Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Revenue Product Segmentation